XML 38 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Intangible Assets, Net
12 Months Ended
Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
Distribution
Solutions
 
Technology
Solutions
 
Total
Balance, March 31, 2016
$
7,987

 
$
1,799

 
$
9,786

Goodwill acquired
2,836

 
22

 
2,858

Acquisition accounting, transfers and other adjustments
(146
)
 
1

 
(145
)
Goodwill impairment

 
(290
)
 
(290
)
Amount reclassified to assets held for sale
(165
)
 

 
(165
)
Goodwill disposed (1)
(30
)
 
(1,078
)
 
(1,108
)
Foreign currency translation adjustments, net
(350
)
 

 
(350
)
Balance, March 31, 2017
$
10,132

 
$
454

 
$
10,586

Goodwill acquired
1,707

 

 
1,707

Acquisition accounting, transfers and other adjustments (2)
369

 
(330
)
 
39

Goodwill impairment (3)
(1,738
)
 

 
(1,738
)
Goodwill disposed (1)
(48
)
 
(124
)
 
(172
)
Amount reclassified to assets held for sale
(2
)
 

 
(2
)
Foreign currency translation adjustments, net
504

 

 
504

Balance, March 31, 2018
$
10,924

 
$

 
$
10,924


(1)
2017 Technology Solutions segment amount represents goodwill disposal associated with Healthcare Technology Net Asset Exchange transaction. Refer to Financial Note 2, “Healthcare Technology Net Asset Exchange” for more information. 2018 Technology Solutions segment amount represents goodwill disposal associated with the sale of our EIS business. Refer to Financial Note 5, “Divestitures” for more information.
(2)
Effective April 1, 2017, our RHP business was transferred from the Technology Solutions segment to the Distribution Solutions segment.
(3)
In 2018, goodwill impairment charges from our international businesses were translated at average exchange rates during the corresponding period and accumulated goodwill impairment losses described below were translated at year-end exchange rates.

As of March 31, 2018, accumulated goodwill impairment loss was $1,755 million primarily in our Distribution Solutions segment. As of March 31, 2017, the accumulated goodwill impairment loss was $290 million primarily in our Technology Solutions segment. Refer to Financial Note 3, “Goodwill Impairment Charges,” for more information on the impairment charges recorded in 2018 and 2017.
Information regarding intangible assets is as follows:
 
March 31, 2018
 
March 31, 2017
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(Years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships
12
 
$
3,619

 
$
(1,550
)
 
$
2,069

 
$
2,893

 
$
(1,295
)
 
$
1,598

Service agreements
12
 
1,037

 
(386
)
 
651

 
1,009

 
(316
)
 
693

Pharmacy licenses
26
 
684

 
(196
)
 
488

 
741

 
(150
)
 
591

Trademarks and trade names
14
 
932

 
(187
)
 
745

 
845

 
(124
)
 
721

Technology
4
 
147

 
(84
)
 
63

 
69

 
(64
)
 
5

Other
4
 
262

 
(176
)
 
86

 
201

 
(144
)
 
57

Total
 
 
$
6,681

 
$
(2,579
)
 
$
4,102

 
$
5,758

 
$
(2,093
)
 
$
3,665

Amortization expense of intangible assets was $503 million, $444 million and $431 million for 2018, 2017 and 2016. Estimated annual amortization expense of intangible assets is as follows: $440 million, $422 million, $405 million, $373 million and $262 million for 2019 through 2023, and $2,200 million thereafter. All intangible assets were subject to amortization as of March 31, 2018 and 2017.

Refer to Financial Note 4, “Restructuring and Asset Impairment Charges,” for more information on intangible asset impairment charges recorded in 2018.